Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.260
+0.090 (2.16%)
At close: Dec 5, 2025, 4:00 PM EST
4.250
-0.010 (-0.23%)
After-hours: Dec 5, 2025, 5:55 PM EST
Adverum Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | 1 | 3.6 | - | 7.5 | - | |
| Revenue Growth (YoY) | - | -72.22% | - | - | - | - | |
| Cost of Revenue | 77.12 | 77.04 | 77.49 | 95.58 | 89.18 | 73.31 | |
| Gross Profit | -77.12 | -76.04 | -73.89 | -95.58 | -81.68 | -73.31 | |
| Selling, General & Admin | 59.84 | 63.12 | 55.06 | 54.73 | 63.38 | 44.64 | |
| Operating Expenses | 111.59 | 63.12 | 55.06 | 54.73 | 63.38 | 44.64 | |
| Operating Income | -188.72 | -139.16 | -128.94 | -150.31 | -145.06 | -117.95 | |
| Interest & Investment Income | 3.92 | 8.23 | 5.75 | 2.67 | 0.58 | 1.56 | |
| EBT Excluding Unusual Items | -184.79 | -130.93 | -123.19 | -147.64 | -144.48 | -116.39 | |
| Merger & Restructuring Charges | - | - | - | -4.7 | - | - | |
| Asset Writedown | - | - | - | -2.12 | -1.06 | - | |
| Pretax Income | -184.79 | -130.93 | -123.19 | -154.46 | -145.54 | -116.39 | |
| Income Tax Expense | - | - | -1.08 | 0.07 | - | 1.11 | |
| Net Income | -184.79 | -130.93 | -122.12 | -154.54 | -145.54 | -117.51 | |
| Net Income to Common | -184.79 | -130.93 | -122.12 | -154.54 | -145.54 | -117.51 | |
| Shares Outstanding (Basic) | 22 | 20 | 10 | 10 | 10 | 9 | |
| Shares Outstanding (Diluted) | 22 | 20 | 10 | 10 | 10 | 9 | |
| Shares Change (YoY) | 26.37% | 96.21% | 1.58% | 1.24% | 15.14% | 32.83% | |
| EPS (Basic) | -8.56 | -6.62 | -12.11 | -15.57 | -14.85 | -13.80 | |
| EPS (Diluted) | -8.56 | -6.62 | -12.11 | -15.57 | -14.85 | -13.80 | |
| Free Cash Flow | -138.45 | -92.85 | -91.71 | -119.91 | -122.95 | -91.14 | |
| Free Cash Flow Per Share | -6.41 | -4.69 | -9.10 | -12.08 | -12.54 | -10.70 | |
| Operating Margin | - | -13915.90% | -3581.72% | - | -1934.12% | - | |
| Profit Margin | - | -13092.70% | -3392.11% | - | -1940.53% | - | |
| Free Cash Flow Margin | - | -9285.00% | -2547.50% | - | -1639.39% | - | |
| EBITDA | -186.22 | -135.51 | -123.3 | -143.78 | -140.41 | -113.79 | |
| D&A For EBITDA | 2.49 | 3.65 | 5.64 | 6.53 | 4.65 | 4.16 | |
| EBIT | -188.72 | -139.16 | -128.94 | -150.31 | -145.06 | -117.95 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.